DNA-histone binding site

The term "DNA-histone epitope binding" does not refer to a specific molecule or receptor but rather describes the **interaction between DNA and histones**, which are basic proteins that package and order eukaryotic DNA into structural units called nucleosomes. Histones act as spools around which DNA winds, enabling compaction necessary for fitting large genomes inside cell nuclei[1][2]. The interaction is primarily non-sequence-specific, involving ionic bonds between the basic residues of histones and the acidic sugar-phosphate backbone of DNA[2]. This interface can be modified by post-translational modifications on histones (such as methylation or acetylation), affecting gene expression by altering chromatin accessibility[1][2]. While this interaction is fundamental to cellular biology, it is not considered a discrete druggable target like an enzyme or receptor. Instead, components involved in regulating this interface—such as histone-modifying enzymes or chaperones—are more commonly targeted in therapeutic strategies[1]. **Note:** The phrase "DNA-histone epitope binding" appears to conflate two concepts—epitopes (typically referring to antibody recognition sites) and the general physical/chemical association between DNA and histones. There is no canonical protein or receptor with this name; thus, it should not be treated as a standard molecular target for drug discovery.

Other names

DNA-histone interactionnucleosome binding sitechromatin-DNA interface